Adenosine 3′,5′-cyclic mononucleotide (cAMP) is one of the most important second messengers which govern cellular signal transductions. Adenylyl cyclases (ACs), which are cAMP-synthesizing enzymes, are responsible for cAMP production during extracellular stimulation or intracellular metabolic alteration. In mammals, 9 transmembrane ACs and 1 soluble AC have been identified and characterized. In the past 2 decades, the biochemical properties of these ACs have been extensively studied. Genetic knockout and transgenic overexpression mouse models of at least 6 ACs have been produced, revealing their specific in vivo functions. An awareness of the importance of microdomains and cellular compartmentation for selective AC regulation has also been fostered. Most intriguingly, a handful of novel AC-binding proteins have recently been reported. Selective binding of ACs to their binding partners allows the precise compartmentalization of ACs and permits unique regulation. Based on recent studies on AC-interacting proteins (particularly Snapin and Ric8a), this review focuses on the importance and possible involvement of AC-interacting proteins in (1) the association of the cAMP signaling pathway with various cellular machineries and (2) the coordination of tightly regulated cAMP signaling by other signaling molecules.

Keywords:
Adenylyl cyclase, cAMP, Ric8a, Snapin, Calcium
This content is only available via PDF.
© 2009 S. Karger AG, Basel
2009
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.